NICE has assessed Neuropad for detecting preclinical diabetic peripheral neuropathy to help the NHS decide whether to use this product.
Neuropad detects low levels of sweat production on a patient’s foot, which may indicate that they have the early stages of diabetic peripheral neuropathy. But there is not enough evidence that this is a reliable indicator. There is also no evidence to suggest that Neuropad is more effective than standard testing for diabetic peripheral neuropathy with a 10 g monofilament.
This page was last updated: